dr. backes on next steps for lenvatinib and weekly paclitaxel in endometrial cancer
Published 4 years ago • 91 plays • Length 0:53Download video MP4
Download video MP3
Similar videos
-
1:14
dr. backes on rationale for lenvatinib and weekly paclitaxel in endometrial cancer
-
0:55
dr. backes on safety profile of lenvatinib and weekly paclitaxel in endometrial cancer
-
0:52
investigating toxicities with lenvatinib plus paclitaxel in ovarian and endometrial cancers
-
1:32
dr. makker on safety signals with lenvatinib and pembrolizumab in endometrial cancer
-
1:08
evaluating the benefits of lenvatinib and paclitaxel in recurrent gynecologic cancers
-
1:39
dr. makker on synergy between lenvatinib and pembrolizumab in endometrial cancer
-
1:30
dr. backes on the utility of sentinel lymph node mapping in cervical cancer
-
1:02
dr. klopp discusses chemoradiation in endometrial cancer
-
0:59
dr. schlumbrecht on remaining challenges in uterine leiomyosarcoma
-
1:39
dr. matulonis discusses qol data from gog-258 in endometrial cancer
-
7:15
rebastinib plus paclitaxel shows encouraging anti-tumor activity in endometrial cancer
-
0:52
dr. birrer on checkpoint inhibitors for endometrial cancer
-
1:46
dr. bible on impact of lenvatinib on treatment landscape of dtc
-
41:09
netwise episode 6: managing symptoms of nets
-
2:10
dr. dizon on pten mutations in endometrial cancer
-
1:01
dr. mayor on neuroendocrine carcinoma in gynecologic tumors
-
1:22
dr. kauff on challenges in treating uterine cancer
-
1:45
dr. yadav on the olaparib/neratinib combo in her2 uterine serous carcinoma
-
0:13
copy of dr. makker on combination approaches in endometrial cancer